Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03891966 · ClinicalTrials.gov registry record · NA

Upper Extremity Post-op Splints: Do They Improve Post-operative Pain?

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
122
Enrollment target

NCT03891966: Completed NA study, sponsored by NYU Langone Health.

NCT03891966 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03891966, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target

Study Summary

The goal of this study is to determine if applying a rigid splint helps to reduce pain following operative fixation of upper extremity fractures. Orthopedic trauma surgeons currently vary in their application of rigid post-operative splints versus soft dressings after certain surgical procedures based on personal preference. In this study, 100 patients undergoing operative fixation of isolated both bone forearm, radial head, olecranon, distal humerus, or humeral shaft fractures will either receive a splint or soft dressing post-operatively. Their pain, medication usage and function will be tracked over the 2- week postoperative period to see if splinting has any impact on outcomes.

Primary Outcome

Best state you can imagine is marked 100and the worst state you can imagine is marked 0 on a line

Interventions

  • PROCEDURE Rigid Splint
  • PROCEDURE Soft Dressing

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2018-11-08
Est. Completion 2023-08-01
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT03891966 record still lists

NCT03891966 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Rigid Splint is the first listed.

NCT03891966 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03891966 about?

NCT03891966 is a clinical study titled "Upper Extremity Post-op Splints: Do They Improve Post-operative Pain?". The goal of this study is to determine if applying a rigid splint helps to reduce pain following operative fixation of upper extremity fractures. Orthopedic trauma surgeons currently vary in their application of rigid post-operative splints versus soft dressings after certain surgical procedures bas...

What is the current status of trial NCT03891966?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2018-11-08. Estimated completion is 2023-08-01.

What interventions are being tested in trial NCT03891966?

The interventions under investigation include: Rigid Splint (PROCEDURE), Soft Dressing (PROCEDURE).

Who is sponsoring clinical trial NCT03891966?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03891966's enrollment target sits among peer trials

122 762nd of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03363373 · 122 participants · Phase 2

    Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

  • NCT03463954 · 122 participants · NA

    Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

  • NCT04503265 · 122 participants · Phase 1

    A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

  • NCT04700527 · 122 participants · Phase 1

    The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03891966, the US trial registry maintained by the National Library of Medicine. NCT03891966 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.